HomeFATE • NASDAQ
add
Fate Therapeutics Inc
Previous close
$3.90
Day range
$3.81 - $4.00
Year range
$1.63 - $8.83
Market cap
443.60M USD
Avg Volume
2.73M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.92M | -96.74% |
Operating expense | 47.28M | -42.71% |
Net income | -48.00M | -154.25% |
Net profit margin | -2.49K | -7,690.41% |
Earnings per share | -0.47 | -147.37% |
EBITDA | -46.25M | -89.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 383.54M | -6.20% |
Total assets | 569.89M | -9.59% |
Total liabilities | 143.78M | -5.94% |
Total equity | 426.12M | — |
Shares outstanding | 113.83M | — |
Price to book | 1.04 | — |
Return on assets | -23.73% | — |
Return on capital | -25.53% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -48.00M | -154.25% |
Cash from operations | -33.35M | -15.56% |
Cash from investing | 17.31M | 85.37% |
Cash from financing | 95.49M | 46,029.47% |
Net change in cash | 79.45M | 511.39% |
Free cash flow | -4.62M | 83.00% |
About
Founded
2007
Website
Employees
181